Takeda Announces Approval of Nuvaxovid COVID-19 Vaccine for Primary and Booster Immunization in…
− Nuvaxovid Intramuscular Injection, containing Matrix-MTM adjuvant, is the first recombinant protein-based COVID-19 vaccine approved for use in Japan…